Advanced Bio,
People-centered Value Creation

With the vision of "Safe Food and Drug, Healthy People, Well-being Society", the MFDS has exerted all-out efforts to safeguard the people and promote the public health by ensuring the safety of all foods, drugs, cosmetics, herbal medicines, and medical devices that we have in our daily lives.

In particular, we have made our utmost efforts to support the biopharmaceutical technologies, a new growth engine for the future in order to immediately provide safe and efficient medicines. We also have closely cooperated with diverse international organizations such as WHO and many regulatory authorities across the globe.

The GBC is the representative event of the MFDS in order to develop Korea into a global hub of the biopharmaceutical industry. It has also served as an opportunity to promote a better regulatory alignment and establish a cooperation network between the biopharmaceutical experts through sharing the latest development trends and global issues in the industry.

I hope it will pave the way for achieving a "People-centered Bioeconomy and Value Creation” and penetrating the global markets. I look forward to meeting you in Seoul in September.

Korea Biomedicine Industry Association (KoBIA) is committed to organizing GBC 2021 successfully.

KoBIA brings together government, industry, university, and research related to biothechonology in Korea. Since established in 2011, KoBIA is growing fast as an association representing Korean biopharmaceutical industry. We will continue to make efforts towards providing biopharmaceutical leaders with useful networking opportunity.